Integral Diagnostics (ASX: IDX) — Perfil da empresa, notícias e dados financeiros
Integral Diagnostics provides diagnostic imaging services in Australia and New Zealand, focusing on quality and accessibility.
Integral Diagnostics
Integral Diagnostics is a healthcare services provider specializing in diagnostic imaging and sub-specialist radiologist services across Australia and New Zealand. The company operates a network of comprehensive medical imaging clinics, hospital-based sites, and specialist centers offering procedures such as magnetic resonance imaging, computed tomography, nuclear medicine, ultrasound, mammography, and general X-ray. Its clinical networks span Victoria, Queensland, Western Australia, New South Wales, South Australia, Tasmania, and the North Island of New Zealand. Serving general practitioners, medical specialists, and public and private hospital contracts, the business delivers diagnostic reporting and interventional radiology procedures across regional and metropolitan communities.
Resumo
Operações
Produtos e/ou serviços de Integral Diagnostics
- Comprehensive Medical Imaging Services: Provision of diagnostic imaging modalities including magnetic resonance imaging, computed tomography, ultrasound, mammography, nuclear medicine, positron emission tomography, and digital radiography across network clinics for general practitioner and specialist referrals.
- Hospital-Based Diagnostic Radiography: Delivery of integrated imaging infrastructure, emergency department radiology support, and specialized diagnostic reporting inside public and private hospital facilities under long-term contract arrangements with regional healthcare networks and private hospital operators.
- Specialized Musculoskeletal Imaging: Specialized diagnostic procedures and image-guided musculoskeletal interventions, including joint injections, spinal procedures, and high-resolution sports injury imaging delivered by sub-specialized radiologists across dedicated metropolitan and regional clinic centers.
- Women's Health & Breast Diagnostics: Focused diagnostic services encompassing digital 3D mammography, breast ultrasound, breast MRI, and image-guided biopsy procedures designed for early detection, oncological assessment, and routine screening programs in dedicated regional healthcare facilities.
- Wellness & Preventive Imaging Services: Whole-body diagnostic scanning and preventive health imaging protocols delivered in partnership with wellness and health management providers to perform proactive health assessments and early detection screening for asymptomatic individuals.
- Teleradiology & Sub-Specialist Reporting: Remote diagnostic image interpretation, emergency teleradiology coverage, and sub-specialist expert consults facilitated through centralized digital picture archiving and communication systems connecting regional clinics with specialized radiologists.
equipe executiva do Integral Diagnostics
- Jason MartinezMD, CEO & Director
- Jennifer Margaret MartinChief Financial Officer
- Julian GullyChief Information Officer
- Melissa WongChief People Officer
- Tony ChenChief Medical Officer
- John MerityCompany Secretary
Últimas notícias sobre a Integral Diagnostics
Comunicados recentes
O que a Integral Diagnostics (IDX) comunicou ao mercado, do mais recente para o mais antigo.
- Change of Director's Interest Notice - Toby Hall Chair
- Application for quotation of securities - IDX
- Notification regarding unquoted securities - IDX
- Release of Ordinary Shares from Escrow
Histórico de dividendos
Dividendos por ação pagos pela Integral Diagnostics, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2027(até o momento) | A$0.0600 | — | — | A$0.0600 |
| FY2026 | A$0.0400 | — | — | A$0.0730 |
| FY2025 | A$0.0330 | A$0.0250 | — | A$0.0580 |
| FY2024 | A$0.0350 | A$0.0250 | — | A$0.0600 |
| FY2023 | A$0.0300 | A$0.0250 | — | A$0.0550 |
Principais indicadores financeiros
Resultados divulgados pela Integral Diagnostics, em AUD.
- Cap. de mercado
- 663,3 mi
- Receita (TTM)
- 788,6 mi
- P/L
- 35.5
- LPA (diluído, TTM)
- 0.1
- Dividend yield
- 4.5%
- Margem de lucro
- 2.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 788,6 mi | 67,7 mi | 21,9 mi | |
| 627,2 mi | 57,5 mi | 4,7 mi | |
| 469,7 mi | 42,2 mi | -60,7 mi | |
| 440,1 mi | 40,1 mi | 25 mi |